Islet Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Islet Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-10-19Clinical Trial Update: Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating temozolomide with or without capecitabine in advanced pancreatic neuroendocrine tumors, including subtypes such as …
-
CLINICAL_TRIALS trial_result · 2021-12-15Clinical Trial Update: Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating regorafenib in advanced or metastatic neuroendocrine tumors has been completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-06-17Clinical Trial Update: Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery [Phase 1, Phase 2]
Phase 1/2 trial evaluating temozolomide with pazopanib in advanced, unresectable pancreatic neuroendocrine tumors; study completed with resu…
-
CLINICAL_TRIALS trial_result · 2018-12-11Clinical Trial Update: FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas [Phase 2]
Phase 2 trial of FOLFIRINOX in metastatic high-grade gastroenteropancreatic neuroendocrine carcinomas was terminated; results posted in 2018…
-
CLINICAL_TRIALS withdrawal · 2017-07-19Clinical Trial Update: Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial of dovitinib lactate for pancreatic neuroendocrine tumors has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-10-08Clinical Trial Update: Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors [Phase 2]
A Phase 2 trial evaluating vatalanib in combination with octreotide for progressive neuroendocrine tumors has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-11-17Clinical Trial Update: Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating sorafenib tosylate in patients with progressive metastatic neuroendocrine tumors has completed; results were posted…
-
CLINICAL_TRIALS withdrawal · 2013-07-10Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy [Phase 2]
A Phase 2 clinical trial of antineoplaston therapy for Merkel cell carcinoma, islet cell carcinoma, neuroendocrine carcinoma, and pituitary …
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 clinical trial update evaluating gefitinib in patients with progressive/metastatic neuroendocrine tumors has completed. The study en…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial of romidepsin for locally advanced or metastatic neuroendocrine tumors was terminated; the document lists the conditions studi…